Pulsatile growth hormone secretion persists in genetic growth hormone-releasing hormone resistance.
AuthorsMaheshwari, Hiralal G
Pezzoli, Suzan S
Shalet, Stephen M
Thorner, Michael O
AffiliationCenter for Endocrinology, Metabolism and Molecular Medicine, Department of Medicine, Northwestern University Medical School, and Veterans Administration Chicago Health System, Lakeside Division, Chicago, Illinois 60611, USA.
MetadataShow full item record
AbstractGrowth hormone (GH) secretion is regulated by GH-releasing hormone (GHRH), somatostatin, and possibly ghrelin, but uncertainty remains about the relative contributions of these hypophysiotropic factors to GH pulsatility. Patients with genetic GHRH receptor (GHRH-R) deficiency present an opportunity to examine GH secretory dynamics in the selective absence of GHRH input. We studied circadian GH profiles in four young men homozygous for a null mutation in the GHRH-R gene by use of an ultrasensitive GH assay. Residual GH secretion was pulsatile, with normal pulse frequency, but severely reduced amplitude (<1% normal) and greater than normal process disorder (as assessed by approximate entropy). Nocturnal GH secretion, both basal and pulsatile, was enhanced compared with daytime. We conclude that rhythmic GH secretion persists in an amplitude-miniaturized version in the absence of a GHRH-R signal. The nocturnal enhancement of GH secretion is likely mediated by decreased somatostatin tone. Pulsatility of residual GH secretion may be caused by oscillations in somatostatin and/or ghrelin; it may also reflect intrinsic oscillations in somatotropes.
CitationPulsatile growth hormone secretion persists in genetic growth hormone-releasing hormone resistance. 2002, 282 (4):E943-51 Am. J. Physiol. Endocrinol. Metab.
JournalAmerican Journal of Physiology. Endocrinology and Metabolism
- Growth hormone (GH) secretion in patients with an inactivating defect of the GH-releasing hormone (GHRH) receptor is pulsatile: evidence for a role for non-GHRH inputs into the generation of GH pulses.
- Authors: Roelfsema F, Biermasz NR, Veldman RG, Veldhuis JD, Frölich M, Stokvis-Brantsma WH, Wit JM
- Issue date: 2001 Jun
- Nocturnal ghrelin pulsatility and response to growth hormone secretagogues in healthy men.
- Authors: Koutkia P, Canavan B, Breu J, Johnson ML, Grinspoon SK
- Issue date: 2004 Sep
- Continuous 24-hour intravenous infusion of recombinant human growth hormone (GH)-releasing hormone-(1-44)-amide augments pulsatile, entropic, and daily rhythmic GH secretion in postmenopausal women equally in the estrogen-withdrawn and estrogen-supplemented states.
- Authors: Evans WS, Anderson SM, Hull LT, Azimi PP, Bowers CY, Veldhuis JD
- Issue date: 2001 Feb
- Clinical pharmacology of human growth hormone and its secretagogues.
- Authors: Root AW, Root MJ
- Issue date: 2002 Apr
- Marked GH secretion after ghrelin alone or combined with GH-releasing hormone (GHRH) in obese patients.
- Authors: Alvarez-Castro P, Isidro ML, Garcia-Buela J, Leal-Cerro A, Broglio F, Tassone F, Ghigo E, Dieguez C, Casanueva FF, Cordido F
- Issue date: 2004 Aug